News
5hon MSN
Home Depot disappoints, Novo Nordisk's GLP-1 updates, an AI warning and more in Morning Squawk
Home Depot kicked off this week's string of retailer earnings reports. Novo Nordisk provided two major updates on its ...
The string of negative updates from Novo Nordisk and positive news flow from the main competitor Eli Lilly has finally ended ...
Shares of Novo Nordisk ( NVO 4.81%), the Danish pharmaceuticals company famed for Ozempic and Wegovy weight loss drugs, ...
The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.
Novo Nordisk A/S innovation and growth continue to shine. Now, it has a partnership with GoodRX Holdings. Click for my ...
GoodRx is joining the GLP-1 action with an announcement Monday to begin selling both Novo Nordisk's GLP-1 drugs, Ozempic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results